IMF Deputy Dan Katz Visits China as Key Economic Review Nears 
U.S. Expected to Expand Travel Ban to More Than 30 Countries 
UN Chief Says Gaza Operation “Fundamentally Wrong” as Concerns Over War Crimes Grow 
Taiwan Opposition Criticizes Plan to Block Chinese App Rednote Over Security Concerns 
New Orleans Immigration Crackdown Sparks Fear as Federal Arrests Intensify 
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative 
China’s Expanding Maritime Military Presence Alarms Taiwan and Japan 
Maduro Confirms “Respectful” Call With Trump, Signals Openness to Diplomatic Dialogue 
Hong Kong Faces Low Turnout in “Patriots-Only” Election Amid Public Grief After Deadly Fire 
U.S. Repatriation Flight Carrying 266 Venezuelan Migrants Lands in Caracas 
China Urged to Prioritize Economy Over Territorial Ambitions, Says Taiwan’s President Lai 
Australia and Japan Strengthen Defence Cooperation Amid Rising Regional Tensions 
Trump and Lula Discuss Trade, Sanctions, and Security in “Productive” Phone Call 
U.S. Defense Chief Pete Hegseth Defends Controversial Second Strike on Suspected Drug-Smuggling Vessel 
Israel Receives Body of Deceased Hostage as Rafah Crossing Reopening Hinges on Final Returns 
California Launches Portal for Reporting Alleged Misconduct by Federal Immigration Agents 
Honduras Election Turmoil Intensifies as Nasralla Blames Trump for Shift in Results 
With the coronavirus or COVID-19 situation in the United States growing worse by the day, lawmakers are all pushed to working together in order to keep the situation under control. Recently, President Donald Trump said that he wants to get rid of the “red tape” and bring in the coronavirus drugs faster to the people.
Politico reports that in an attempt to bring treatment for coronavirus faster to the infected people, Trump is planning to get rid of the red tape “like nobody’s ever done before.” The President instructed the Food and Drug Administration to fast forward the authorization of the drugs needed. However, he did not disclose any details and instead, along with other health officials, noted the steps that the government has taken as of late to start the clinical trials of potential treatments for coronavirus.
Trump also suggested some programs that the administration can utilize to get experimental drugs to those affected as soon as possible outside the clinical trials. One of those approaches was the “Right to Try” which was established after a 2018 law that both Trump and vice president Mike Pence supported to help those who have no treatment options.
However, that suggestion was met with some skepticism from experts, who feel that the Right to Try approach would only induce false hope in patients and that there are other ways to help people access experimental medicines. Fortunately, Gilead has already provided its antiviral drug called remdesivir to patients with coronavirus under compassionate use rules. This drug was mentioned by Trump and added the drugs that were used to treat malaria, hydroxychloroquine, and chloroquine, may be helpful in combating the virus, but more information is needed.
Meanwhile, the outcome of the coronavirus response package being prepared by lawmakers in both the House and Senate would now rest in the hands of Senate Majority Leader Mitch McConnell and Senate Minority Leader Chuck Schumer, with the Senate taking up “Phase 3” of an economic stimulus package that would be able to keep the economy afloat. The country’s economy wound up on the rocks due to the pandemic, with the stock market seeing a drastic drop in numbers, leading to a crisis.
McConnell and Schumer have not seen eye to eye on many issues, but this “Phase 3” coronavirus response package will have to reach a bipartisan agreement for it to pull through.
